These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11685915)

  • 1. The Conduit Artery Functional Endpoint (CAFE) study in ASCOT.
    Williams B; O'Rourke M;
    J Hum Hypertens; 2001 Aug; 15 Suppl 1():S69-73. PubMed ID: 11685915
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
    Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
    Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
    Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practice.
    Prandin MG; Cicero AF; Dormi A; Veronesi M; Cosentino ER; Borghi C
    Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):512-8. PubMed ID: 19699070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 7. [CBO guideline 'high blood pressure' (revision)].
    de Bruijckere PA
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439. PubMed ID: 11901947
    [No Abstract]   [Full Text] [Related]  

  • 8. [CBO guideline 'high blood pressure' (revision)].
    Polak BC
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439-40. PubMed ID: 11901948
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study.
    Nadar S; Lim HS; Beevers DG; Lip GY
    J Hum Hypertens; 2002 Dec; 16(12):815-7. PubMed ID: 12522461
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiology 2008].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1341-3. PubMed ID: 18553258
    [No Abstract]   [Full Text] [Related]  

  • 11. [HMA CoA reductase inhibitors].
    Kostner GM
    Wien Med Wochenschr; 1999; 149(5-6):109-10. PubMed ID: 10408000
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Williams B; Lacy PS; Thom SM; Cruickshank K; Stanton A; Collier D; Hughes AD; Thurston H; O'Rourke M; ; ;
    Circulation; 2006 Mar; 113(9):1213-25. PubMed ID: 16476843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The smart take on statins.
    Kotz D
    US News World Rep; 2008 Feb; 144(5):41-5. PubMed ID: 18361207
    [No Abstract]   [Full Text] [Related]  

  • 14. The new cardiovascular disease prevention guidelines: what you need to know.
    Campos-Outcalt D
    J Fam Pract; 2014 Feb; 63(2):89-93. PubMed ID: 24527471
    [No Abstract]   [Full Text] [Related]  

  • 15. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
    Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
    Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects?
    Correa V; Gus M; Fuchs FD
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):775-9. PubMed ID: 20528635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is endothelial dysfunction reversible?
    Schmieder RE; Schobel HP
    Am J Cardiol; 1995 Jul; 76(2):117A-121A. PubMed ID: 7604785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated augmentation index].
    Baulmann J; Schunkert H
    Dtsch Med Wochenschr; 2012 Feb; 137(6):281-2. PubMed ID: 22294114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of cholesterol synthesizing enzymes (CSE) inhibitors].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1999 Jun; 22(6):184-6. PubMed ID: 10394795
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of seven different modalities of antihypertensive therapy on pulse pressure in patients with newly diagnosed stage I hypertension.
    Alici G; Aliyev F; Bellur G; Okcun B; Türkoğlu C; Karpuz H
    Cardiovasc Ther; 2009; 27(1):4-9. PubMed ID: 19207474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.